Intelligent blood glucose monitoring device for developed glucose regulation of 18F-FDG PET viable myocardium

Abstract

The invention discloses an intelligent blood glucose monitoring device for developed glucose regulation of a 18F-FDG PET viable myocardium. The intelligent blood glucose monitoring device comprises aninformation acquisition module, wherein the information acquisition module is used for acquiring blood glucose information on a subject; an electronic transmission module, wherein the electronic transmission module is used for generating a blood glucose-time variation curve for the acquired blood glucose information on the subject; a display module, wherein the display module is used for displaying the blood glucose-time variation curve generated by the electronic transmission module; and a threshold comparison module, wherein the threshold comparison module is used for setting a dangerous threshold of hypoglycemia of the subject. According to the intelligent blood glucose monitoring device, blood glucose conditions of a sufferer are concerned in real time in a whole glucose loading process, insulin of a certain dosage is offered when the blood glucose rises obviously and is greater than the threshold, then, 18F-FDG is injected when a slope coefficient of a blood glucose descending curve is maximum, thus, the intake of glucose by viable myocardium is maneuvered to the maximum, the image quality is improved, and successful development is ensured; and pain and discomfort of the sufferer caused by repeated blood-glucose-measurement pricking in a short time can be avoided, and patient compliance is improved.

Description

technical field [0001] The invention relates to the field of blood sugar detection, more specifically, it relates to a blood sugar monitoring intelligent device for 18F-FDG PET living myocardium imaging and sugar regulation. Background technique [0002] Viable myocardium refers to ischemic myocardium with dysfunction, and its function can gradually recover after blood perfusion is restored. Revascularization therapy can improve the cardiac function and prognosis of patients with coronary heart disease by restoring the blood perfusion of ischemic myocardium, and is an important means of treating coronary heart disease. At present, the number of viable myocardium has been widely used to predict the recovery of systolic function after revascularization in patients with coronary heart disease and heart failure. The reversal of ventricular remodeling, the improvement of quality of life, exercise capacity and survival rate are important basis for guiding clinical decision-making....

AI Technical Summary

Problems solved by technology

In addition, this method has certain risks, and the patient may have a hypoglycemic reaction. If it is not discovered and rescued in time, it will cause serious consequences.

Images